NHI
National Health Investors, Inc. NYSE Listed Oct 9, 1991$75.53
+0.65%
vs $75.04
Mkt Cap $3.7B
52w Low $67.94
32.4% of range
52w High $91.38
50d MA $75.20
200d MA $78.83
P/E (TTM)
24.6x
EV/EBITDA
15.7x
P/B
2.3x
Debt/Equity
0.8x
ROE
9.3%
P/FCF
16.1x
RSI (14)
32.90
ATR (14)
$2.06
Beta
0.66
50d MA
$75.20
200d MA
$78.83
Avg Volume
804.8K
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
222 Robert Rose Drive · Murfreesboro, TN 37129 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | AMC | 0.92 | 0.82 | -11.1% | 75.71 | -2.5% | -3.5% | +1.1% | +1.6% | +0.3% | -2.4% | — |
| Feb 26, 2026 | AMC | 0.80 | 1.22 | +52.3% | 87.68 | +0.4% | -4.1% | +4.2% | -0.9% | -2.2% | -1.0% | — |
| Nov 6, 2025 | AMC | 1.24 | 1.32 | +6.5% | 75.31 | +1.4% | +2.0% | -0.1% | -0.0% | -0.7% | +0.9% | — |
| Aug 6, 2025 | AMC | 1.16 | 1.22 | +5.2% | 72.72 | +2.6% | +2.5% | +0.5% | +0.5% | +0.4% | -1.5% | — |
| May 5, 2025 | AMC | 1.13 | 1.15 | +1.8% | 76.04 | -0.3% | +0.4% | +0.3% | -0.9% | +1.2% | -1.6% | — |
| Feb 25, 2025 | AMC | 1.10 | 1.13 | +2.7% | 71.29 | +0.1% | -0.2% | +0.1% | +0.6% | +2.3% | -0.5% | — |
| Nov 5, 2024 | AMC | 1.07 | 1.03 | -3.7% | 76.73 | +0.0% | +0.0% | +3.8% | +2.0% | -0.1% | -1.0% | — |
| Aug 6, 2024 | AMC | 1.10 | 1.18 | +7.3% | 74.33 | +1.1% | +0.4% | -1.0% | +1.1% | -1.2% | +0.8% | — |
| May 6, 2024 | AMC | 1.05 | 1.10 | +4.8% | 64.25 | +0.5% | +2.2% | -0.0% | -0.3% | -0.2% | +0.9% | — |
| Feb 20, 2024 | AMC | 1.08 | 1.09 | +0.9% | 53.24 | +0.5% | +6.6% | +1.5% | +0.3% | +0.7% | +1.2% | — |
| Nov 7, 2023 | AMC | 1.08 | 1.08 | +0.0% | 50.37 | -0.3% | +2.2% | -2.3% | +1.1% | +0.8% | +4.8% | — |
| Aug 8, 2023 | AMC | 0.69 | 0.92 | +33.3% | 55.00 | -0.9% | -6.4% | -0.3% | +1.3% | -0.5% | -0.9% | — |
| May 9, 2023 | AMC | 0.99 | 1.11 | +12.1% | 49.26 | +2.0% | +8.2% | +0.3% | +0.3% | -0.8% | -1.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $83.35 | $82.26 | -1.3% | -8.2% | +1.4% | -0.8% | +0.2% | -0.7% |
| Apr 22 | Truist | Maintains | Buy → Buy | — | $83.35 | $82.26 | -1.3% | -8.2% | +1.4% | -0.8% | +0.2% | -0.7% |
| Apr 22 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $83.35 | $82.26 | -1.3% | -8.2% | +1.4% | -0.8% | +0.2% | -0.7% |
| Mar 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $82.79 | $82.78 | -0.0% | -0.7% | +0.3% | -1.9% | +1.1% | +1.7% |
| Mar 12 | Truist | Maintains | Buy → Buy | — | $85.21 | $85.00 | -0.2% | +0.4% | -0.4% | +1.3% | -0.6% | -0.6% |
| Dec 16 | Truist | Maintains | Buy → Buy | — | $78.03 | $78.51 | +0.6% | -1.6% | +1.0% | +1.0% | -0.7% | -1.8% |
| Dec 4 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $78.85 | $79.05 | +0.3% | +0.2% | -0.8% | +0.5% | -0.6% | -2.0% |
| Nov 25 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $78.77 | $79.16 | +0.5% | +0.8% | +0.3% | -0.2% | -1.5% | -0.1% |
| Aug 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $76.75 | $76.95 | +0.3% | +1.3% | -0.1% | +0.8% | -1.3% | +0.1% |
| Aug 15 | Truist | Maintains | Buy → Buy | — | $74.25 | $74.18 | -0.1% | +0.6% | +0.3% | +1.7% | +1.0% | +0.6% |
| Jul 10 | KeyBanc Capital Markets | Upgrade | Sector Weight → Overweight | — | $70.28 | $71.22 | +1.3% | +1.2% | +0.2% | +1.4% | -2.3% | +0.2% |
| Jun 9 | Truist | Maintains | Hold → Hold | — | $72.51 | $72.38 | -0.2% | -1.0% | +0.1% | -0.6% | +0.3% | -0.9% |
| Mar 19 | Truist | Maintains | Hold → Hold | — | $76.06 | $76.06 | +0.0% | -0.7% | -1.0% | -1.9% | +1.9% | -1.2% |
| Mar 17 | Wedbush | Maintains | Outperform → Outperform | — | $75.10 | $75.00 | -0.1% | +0.5% | +0.8% | -0.7% | -1.0% | -1.9% |
| Dec 23 | Truist | Maintains | Hold → Hold | — | $69.85 | $69.85 | +0.0% | -1.1% | +0.5% | -0.0% | -0.8% | +0.1% |
| Aug 30 | Truist | Maintains | Hold → Hold | — | $80.48 | $80.82 | +0.4% | +1.2% | -1.7% | +2.6% | +0.5% | -0.2% |
| Jun 26 | Truist | Maintains | Hold → Hold | — | $66.68 | $66.19 | -0.7% | +0.3% | +1.0% | +0.2% | -0.3% | +1.2% |
| May 30 | Wells Fargo | Maintains | Overweight → Overweight | — | $64.04 | $64.45 | +0.6% | +1.9% | +1.3% | +1.9% | -0.5% | -0.7% |
| Apr 4 | Truist | Maintains | Hold → Hold | — | $59.89 | $60.56 | +1.1% | -1.0% | +1.4% | +1.4% | -0.0% | -4.3% |
| Mar 18 | Wedbush | Maintains | Outperform → Outperform | — | $60.10 | $60.06 | -0.1% | +0.8% | +1.2% | -0.5% | +1.7% | -1.2% |
| Mar 12 | BMO Capital | Upgrade | Market Perform → Outperform | — | $59.00 | $59.87 | +1.5% | +0.9% | +0.6% | -0.8% | +1.1% | +0.8% |
| Feb 26 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $57.76 | $59.36 | +2.8% | +0.7% | +1.2% | -0.6% | -1.7% | +0.4% |
| Feb 26 | Wedbush | Upgrade | Neutral → Outperform | — | $57.76 | $59.36 | +2.8% | +0.7% | +1.2% | -0.6% | -1.7% | +0.4% |
| Nov 28 | Stifel | Maintains | Hold → Hold | — | $54.12 | $53.85 | -0.5% | +0.6% | +0.0% | -0.4% | +2.9% | +0.1% |
| Nov 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $54.30 | $54.04 | -0.5% | -0.3% | +0.6% | +0.0% | -0.4% | +2.9% |
| May 11 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $53.30 | $52.50 | -1.5% | +0.3% | +0.3% | -0.8% | -1.5% | +1.8% |
| Mar 29 | Credit Suisse | Maintains | Neutral → Neutral | — | $49.75 | $49.94 | +0.4% | +1.8% | +0.3% | +1.5% | -2.7% | -1.2% |
| Dec 9 | Credit Suisse | Upgrade | Underperform → Neutral | — | $56.54 | $57.53 | +1.8% | +0.3% | +0.2% | -0.3% | -1.6% | +0.2% |
| Sep 26 | Truist | Maintains | Hold → Hold | — | $59.24 | $58.96 | -0.5% | -4.8% | -0.4% | +2.2% | -3.7% | +2.2% |
| Jun 21 | BMO Capital | Downgrade | Outperform → Market Perform | — | $60.76 | $59.17 | -2.6% | -3.2% | +1.1% | +2.5% | +1.1% | -0.1% |
| Apr 19 | BMO Capital | Maintains | Outperform → Outperform | — | $54.59 | $54.88 | +0.5% | +0.6% | +1.3% | -0.4% | -1.1% | -1.1% |
| Jan 7 | BMO Capital | Upgrade | Market Perform → Outperform | — | $59.27 | $59.99 | +1.2% | +2.9% | +0.7% | -1.9% | -2.4% | +1.6% |
| Jul 23 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $67.57 | $67.96 | +0.6% | +0.4% | -0.2% | +1.3% | -0.9% | -0.1% |
| Jun 18 | BMO Capital | Upgrade | Underperform → Market Perform | — | $65.62 | $65.94 | +0.5% | -0.7% | +1.3% | +2.2% | +0.7% | +1.4% |
| Mar 30 | Capital One | Downgrade | Overweight → Equal Weight | — | $74.57 | $72.78 | -2.4% | -2.3% | -0.8% | +3.6% | -0.2% | -0.2% |
| Mar 30 | Capital One Financial | Downgrade | Overweight → Equal Weight | — | $74.57 | $72.78 | -2.4% | -2.3% | -0.8% | +3.6% | -0.2% | -0.2% |
| Jan 13 | Mizuho | Downgrade | Neutral → Underperform | — | $66.19 | $65.25 | -1.4% | +1.1% | +0.5% | +0.9% | -3.2% | +1.3% |
| Jan 8 | BMO Capital | Downgrade | Market Perform → Underperform | — | $66.84 | $65.68 | -1.7% | -0.3% | -1.6% | +1.0% | +1.1% | +0.5% |
| Dec 14 | KeyBanc Capital Markets | Upgrade | Underweight → Sector Weight | — | $67.03 | $68.31 | +1.9% | -0.4% | +3.0% | +0.1% | +1.5% | +0.3% |
| Dec 14 | KeyBanc | Upgrade | Underweight → Sector Weight | — | $67.03 | $68.31 | +1.9% | -0.4% | +3.0% | +0.1% | +1.5% | +0.3% |
| Jun 24 | SunTrust Robinson Humphrey | Maintains | Hold → Hold | — | $59.29 | $58.17 | -1.9% | -3.1% | +3.8% | -1.0% | +2.2% | +0.6% |
| Jun 17 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $64.54 | $65.09 | +0.9% | -2.8% | +1.1% | -5.5% | -0.6% | -0.5% |
| May 22 | Mizuho | Downgrade | Buy → Neutral | — | $53.89 | $53.80 | -0.2% | -1.7% | +7.2% | +3.5% | -1.7% | -4.0% |
| May 14 | KeyBanc Capital Markets | Maintains | Underweight → Underweight | — | $47.74 | $46.29 | -3.0% | -0.4% | -1.7% | +17.5% | -1.3% | -1.4% |
| May 14 | KeyBanc | Maintains | Underweight → Underweight | — | $47.74 | $46.29 | -3.0% | -0.4% | -1.7% | +17.5% | -1.3% | -1.4% |
| Apr 23 | SunTrust Robinson Humphrey | Maintains | Hold → Hold | — | $50.32 | $50.33 | +0.0% | -0.1% | -0.8% | +6.4% | +2.8% | +4.5% |
| Apr 21 | KeyBanc Capital Markets | Maintains | Underweight → Underweight | — | $50.93 | $48.71 | -4.4% | -2.0% | +0.8% | -0.1% | -0.8% | +6.4% |
| Apr 21 | KeyBanc | Maintains | Underweight → Underweight | — | $50.93 | $48.71 | -4.4% | -2.0% | +0.8% | -0.1% | -0.8% | +6.4% |
| Mar 26 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $48.77 | $49.18 | +0.8% | +10.0% | +1.4% | -3.9% | -5.3% | -15.4% |
| Jan 7 | BMO Capital | Upgrade | Underperform → Market Perform | — | $81.12 | $81.90 | +1.0% | -0.0% | +0.0% | +0.8% | +1.0% | +1.7% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | MCCABE ROBERT A JRDir | — | Buy | 890 | $71.65 | $64K | 44,158 | +1.30% | +2.92% |
| Jun 5, 2026 | Mendelsohn D. EricDir/Off | CEO and President | Buy | 1,500 | $68.84 | $103K | 133,316 | -1.42% | +0.19% |
8-K · 5.02
!!! Very High
National Health Investors, Inc. -- 8-K 5.02: Executive Change
Jul 27
8-K · 2.01
!!! Very High
National HealthCare Corporation -- 8-K 2.01: Acquisition Completed
Jul 1
8-K · 1.02
!! High
National HealthCare Corporation -- 8-K 1.02: Material Agreement Terminated
May 27
8-K · 7.01
! Medium
National Health Investors, Inc. -- 8-K 7.01: Regulation FD Disclosure
National Health Investors disclosed material non-public information in Exhibit 99.1, requiring investors to review the attached document for details on developments potentially affecting the healthcare real estate investment trust's operations or financial outlook.
May 4
8-K · 2.02
!! High
National Health Investors, Inc. -- 8-K 2.02: Earnings Results
National Health Investors reported Q1 2026 earnings, providing investors with updated financial performance metrics to assess the company's operational efficiency and dividend sustainability as a healthcare REIT.
May 4
8-K · 5.02
!!! Very High
National Health Investors -- 8-K 5.02: Executive Change
National Health Investors appointed John L. Spaid and Todd Siefert as Executive Vice Presidents effective June 1, 2026, signaling potential operational restructuring within the healthcare real estate investment trust.
Apr 23
8-K · 1.01
!! High
National Healthcare Corp. -- 8-K 1.01: Material Agreement
National Healthcare Corp. agreed to sell assets to National Health Investors, Inc. for $560 million, potentially reducing NHC's operational footprint while providing capital for debt reduction or strategic investments.
Apr 22
8-K · 1.01
!! High
National Health Investors -- 8-K 1.01: Material Agreement
National Health Investors agreed to acquire properties valued at $560 million, potentially expanding its healthcare real estate portfolio and enhancing future revenue streams.
Apr 22
8-K · 1.01
!! High
National Health Investors -- 8-K 1.01: Material Agreement
National Health Investors is receiving a $5 million non-refundable deposit from a purchaser with termination rights through May 29, 2026, indicating a significant asset sale or transaction under negotiation.
Apr 21
8-K · 7.01
! Medium
National Health Investors -- 8-K 7.01: Regulation FD Disclosure
National Health Investors disclosed material information to investors via Regulation FD, requiring review of the attached exhibit to understand the specific announcement's impact on the REIT's operations or financial outlook.
Feb 26
8-K
National Health Investors -- 8-K Filing
National Health Investors expanded its skilled nursing facility portfolio with a $105.5 million acquisition, bringing total SHOP investments to $740 million and positioning the company for increased organic net operating income growth.
Feb 26
8-K · 7.01
! Medium
National Health Investors -- 8-K 7.01: Regulation FD Disclosure
National Health Investors disclosed non-material information via Regulation FD that is not incorporated into SEC filings and carries no liability under securities laws.
Feb 26
8-K · 5.02
!!! Very High
National Health Investors -- 8-K 5.02: Executive Change
Lilly H. Donohue joined National Health Investors' board as a director, expanding the company's governance structure and potentially bringing additional expertise to the REIT's strategic oversight.
Feb 23
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Portfolio Management Llc | 4,142,216 | $335M | New | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 2,084,620 | $169M | New | Mar 2026 |
| 3 | Principal Financial Group Inc | 1,668,006 | $127M | Added | Dec 2025 |
| 4 | Prudential Financial Inc | 1,137,183 | $92M | Added | Mar 2026 |
| 5 | Jpmorgan Chase & Co | 986,592 | $81M | — | Mar 2026 |
| 6 | Bank Of America Corp /de/ | 992,802 | $80M | Added | Mar 2026 |
| 7 | Millennium Management | 761,993 | $62M | Added | Mar 2026 |
| 8 | Northern Trust Corp | 562,847 | $46M | Added | Mar 2026 |
| 9 | Bank Of New York Mellon Corp | 514,731 | $42M | Reduced | Mar 2026 |
| 10 | Morgan Stanley | 475,138 | $36M | Added | Dec 2025 |
| 11 | Qube Research & Technologies Ltd | 429,547 | $35M | Added | Mar 2026 |
| 12 | Two Sigma Investments, Lp | 420,074 | $34M | Added | Mar 2026 |
| 13 | Bowen Hanes & Co Inc | 260,000 | $21M | — | Mar 2026 |
| 14 | Susquehanna International Group, Llp | 254,389 | $21M | Added | Mar 2026 |
| 15 | Algert Global Llc | 145,580 | $12M | Added | Mar 2026 |
| 16 | Marshall Wace, Llp | 134,141 | $11M | Reduced | Mar 2026 |
| 17 | Citadel Advisors Llc | 133,124 | $11M | Added | Mar 2026 |
| 18 | Ubs Group Ag | 127,634 | $10M | Reduced | Mar 2026 |
| 19 | Nuveen, Llc | 113,797 | $9M | Added | Mar 2026 |
| 20 | Sg Americas Securities, Llc | 110,587 | $9M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$3.66B
Enterprise Value
$4.55B
P/E (TTM)
24.56x
Forward P/E
22.30x
PEG Ratio
-7.19x
P/B
2.30x
P/S
8.82x
P/FCF
16.13x
EV/EBITDA
15.73x
Shares Out
47.1M
Financials (TTM)
Revenue
$402.9M
Net Income
$148.1M
EBITDA
$289.2M
Free Cash Flow
$220.3M
Op Cash Flow
$240.2M
EPS Basic
$3.03
EPS Diluted
$3.10
EPS Forward
$3.39
Gross Margin
61.3%
Op Margin
48.5%
Net Margin
36.8%
Balance Sheet
Total Assets
$2.80B
Total Liab.
$1.26B
Total Equity
$1.54B
Cash
$19.6M
LT Debt
$1.04B
Book Value/Sh
$32.85
Debt/Equity
0.76x
Current Ratio
2.48
Quick Ratio
2.48
Returns & Growth
ROE
9.3%
ROA
5.1%
ROIC
7.0%
Rev Growth YoY
+12.9%
EPS Growth YoY
-3.5%
Price Returns
2W
-6.2%
1M
-1.3%
3M
+1.6%
6M
-10.7%
12M
+3.2%
Technicals
52W High
$91.38
52W Low
$67.94
50d MA
$75.20
200d MA
$78.83
RSI (14)
32.90
ATR (14)
$2.06
Beta
0.66
Avg Volume
805K
Dividends
Div Rate
$3.62
Div Yield
4.7%
Frequency
4
Ex-Div Date
Mar 31, 2026
Analyst Price Targets
Consensus
$85.40
High
$88.00
Low
$83.00
Median
$85.00
Data updated apr 26, 2026 3:00pm
· Source: financialmodelingprep.com